Arbutus to Report Second Quarter 2024 Financial Results and Provide Corporate Update
July 18, 2024 07:30 ET
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., July 18, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a...